ERBB2 and breast cancer: A recent study reported that patients with HER2-low breast cancer, like those with HER2-positive breast cancer, exhibited an increased risk of brain metastasis compared to HER2-zero breast cancer, emphasizing the need for vigilant surveillance [8].